Financial Reports and Publications - Sanofi
Find the latest Sanofi financial statements and reports, offering detailed insights into our fiscal performance and strategic financial planning.
Environment, Social, Governance - Sanofi
Apr 30, 2024 · Environment, Social, Governance. As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Paul Hudson - Sanofi
Paul Hudson is reshaping Sanofi into a modern healthcare company with the ambition to transform the practice of medicine. Paul and the Sanofi teams are focusing efforts to discover, develop, manufacture, and make accessible breakthrough medicines and vaccines for people around the world.
Sanofi Careers: Explore Job Opportunities
Embark on a career with Sanofi and contribute to innovative healthcare solutions in a flexible, inclusive environment. Explore your opportunities today.
Sanofi Ireland: global healthcare and pharmaceutical company
We develop and manufacture healthcare solutions within many therapeutic areas: consumer self-care, cardiovascular disease, diabetes, multiple sclerosis, thrombosis, rare diseases, type 2 inflammation (e.g. atopic dermatitis) and vaccines.
Precautions to be taken before handling or administering VAXIGRIP TETRA: For instructions on preparation of VAXIGRIP TETRA before administration, see section 6.6.
Influenza Vaccine - Sanofi
Influenza (flu) does more damage than most people realize. Find out more about Influenza and Sanofi's contribution to research and vaccines.
Sanofi Australia & New Zealand
Our medical information service is available between 8am – 6pm AEST weekdays. An after-hours message service is available for urgent product enquiries, please call 1800 818 806 within Australia, or 0800 283 684 within New Zealand and follow the prompts.
Where we are - Sanofi
Explore the global footprint of Sanofi with locations and offices worldwide, dedicated to healthcare innovation and improving lives worldwide.
SG/EPI oral/1023/CCDS V38 5 mitochondrial DNA as well as the nuclear-encoded POLG gene. In particular, acute liver failure and liver-related deaths have been associated with valproate treatment at a higher rate in patients with hereditary